Testing effectiveness (Phase 2)Study completedNCT02005848
What this trial is testing
Phase II Study to Evaluate the Efficacy and Safety of Glassia® in Type-1 Diabetes
Who this might be right for
New Onset Type-1 Diabetes
Kamada, Ltd. 70
Showing 20 of 0 results